Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.

about

Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.

Item

http://www.wikidata.org/entity/Q47253710

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inhibitor repurposing reveals ...... ses as the targets of AZD1480.

@en

Inhibitor repurposing reveals ...... ses as the targets of AZD1480.

@nl

type

Item

label

Inhibitor repurposing reveals ...... ses as the targets of AZD1480.

@en

Inhibitor repurposing reveals ...... ses as the targets of AZD1480.

@nl

prefLabel

Inhibitor repurposing reveals ...... ses as the targets of AZD1480.

@en

Inhibitor repurposing reveals ...... ses as the targets of AZD1480.

@nl

P1476

Inhibitor repurposing reveals ...... ases as the targets of AZD1480

@en

P2093

Iva Gudernova

http://www.w3.org/2001/XMLSchema#string

Jana Fialova Kucerova

http://www.w3.org/2001/XMLSchema#string

Lukas Balek

http://www.w3.org/2001/XMLSchema#string

Miroslav Varecha

http://www.w3.org/2001/XMLSchema#string

Veronika Palusova

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Cell signaling by receptor tyrosine kinases

CDD: a Conserved Domain Database for the functional annotation of proteins

A census of human cancer genes

Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications

Biochemical and X-ray crystallographic studies on shikimate kinase: The important structural role of the P-loop lysine

Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.

AZD1480 blocks growth and tumorigenesis of RET- activated thyroid cancer cell lines

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

P304

109319-109331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22674

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29312610

http://www.w3.org/2001/XMLSchema#string

P932

5752523

http://www.w3.org/2001/XMLSchema#string